Clinical Trials 101 for Lymphoma Patients
Clinical trials play a vital role in the treatment landscape, but many patients have questions about them. Join Dr. Peter Martin, a lymphoma specialist, for this crash course to learn all about clinical trials and the current state of lymphoma trials. Come ready with your questions for the discussion based Q&A!
Hannah introduces the agenda and our featured speaker Peter Martin, MD
Dr. Martin talks about clinical trials
Come with your questions and we will answer them!
Peter Martin, MD
Dr. Peter Martin is a Professor of Medicine and Chief of the Lymphoma Program at Weill Cornell Medicine. Dr. Martin completed his residency in internal medicine and fellowship in hematology at McGill University. Prior to joining the faculty at Weill Cornell Medical College, he completed a Master's Degree in Clinical Investigation and Translational Research at the Weill Cornell School of Graduate Sciences. Dr. Martin specializes in caring for patients with lymphoma. His research focuses on the clinical investigation of new and promising therapies.
Hannah Loosle
Hannah joined HealthTree Foundation as the Lymphoma Education Manager in 2024. She is a Certified Health Education Specialist and is passionate about helping patients feel empowered through education and connection. Before joining HealthTree, Hannah worked in healthcare policy helping patients advocate for better care, research, and funding. Hannah enjoys baking and going to concerts in her free time.